Robert E. Fricke - Concepedia

Author

Robert E. Fricke

Also Known As

R E FRICKE, R FRICKE, R Fricke, R. E. FRICKE, R. Fricke, R.E. Fricke, R. E. FRICKE, ROBERT E. FRICKE, Robert E. Fricke, Robert Fricke

Publications

471

Citations

H-Index

Concepts

All Affiliations

Bayer (Germany)Mayo Clinic Orion Corporation (Finland)

About

Robert E. Fricke is an author at Bayer (Germany) specializing in medicine, pathology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	63
2	Public Health	1	1	21
3	Biochemistry	1	1	11
4	Diagnostic Sciences	1	1	14
5	Nephrology	1	1	14

Robert E. Fricke

Publications

288

Citations

H-Index

Page 1

	Year	Citations
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies Christian Zurth, Mikko Koskinen, Robert E. Fricke, European Journal of Drug Metabolism and Pharmacokinetics	2019	94
Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial Neal D. Shore, Christian Zurth, Robert E. Fricke, Targeted Oncology	2019	90
The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam Herbert Wiesinger, Stefan Klein, Antje Rottmann, Clinical Pharmacology & Therapeutics	2020	29
Carcinoma of the Cervical Stump David G. Decker, Arthur B. Hunt, Robert E. Fricke, American Journal of Obstetrics and Gynecology Cervical Cancer ManagementCervical CancerMedicineHistopathologyPathology	1957	21
Radium Therapy in Carcinoma of the Female Urethra Robert E. Fricke, James T. McMillan Radiology UrologySurgical OncologyVulvar DiseasesFemale UrethraAnterior Urethra	1949	17
Peyronie’S Disease and its Treatment with Radium Robert E. Fricke, James H. Varney The Journal of Urology Urological ResearchUrologyUrology1 Apr 1948PeyronieMedicineAntiparasitic Agent	1948	14
Pharmacokinetics of asundexian with combined CYP3A and P‐gp inhibitors and an inducer: Target in vitro and in vivo studies Friederike Kanefendt, Christine Brase, Natalia A. Jungmann, British Journal of Clinical Pharmacology	2023	12
Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3 Roland Heinig, Robert E. Fricke, Sebastian Wertz, European Journal of Drug Metabolism and Pharmacokinetics Molecular PharmacologyPharmaceutical SciencePharmacological StudyBiochemistryMedicine	2022	11

Page 1